Posted inLegal & Regulatory and Reimbursement Joint FDA Advisory Committee Votes Against Tanezumab by Kim DelMonico April 7, 2021October 24, 2024
Posted inLegal & Regulatory and Reimbursement New Nerve Growth Factor Inhibitor Submitted to FDA by Elizabeth Hofheinz, M.P.H., M.Ed. March 20, 2020November 1, 2024
Posted inLarge Joints and Extremities Pfizer Pledges $1M to Bring Arthritis to Its Knees by Elizabeth Hofheinz, M.P.H., M.Ed. April 27, 2018November 1, 2024
Posted inLegal & Regulatory and Reimbursement Pfizer’s Quirky Settlement Raises Brows by Jessica Mehta June 13, 2017October 24, 2024